| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |